Elżbieta Ber - Concepedia

Author

Elżbieta Ber

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

E BER, ELZBIETA BER, Elzbieta Ber, Elżbieta Ber

Publications

639

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Elżbieta Ber is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	498
2	Biochemistry	3	3	369
3	Natural Sciences	2	2	274
4	Immunology	2	2	129
5	Cell Biology	1	1	117

Elżbieta Ber

Publications

613

Citations

H-Index

Page 1

	Year	Citations
Structural Optimization Affording 2-(<i>R</i>)-(1-(<i>R</i>)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(<i>S</i>)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Journal of Medicinal Chemistry Orally ActivePharmacotherapyPharmaceutical ChemistryVascular PermeabilityMolecular Pharmacology	1998	203
In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists N.M.J. Rupniak, F.D. Tattersall, Angela Williams, European Journal of Pharmacology MedicineReceptor Tyrosine KinaseImmunologyAnti-emetic ActivityExperimental Pharmacology	1997	117
Phosphorylated Morpholine Acetal Human Neurokinin-1 Receptor Antagonists as Water-Soluble Prodrugs Jeffrey J. Hale, Sander G. Mills, Malcolm MacCoss, Journal of Medicinal Chemistry Regioselective DibenzylphosphorylationBiochemistryMedicineLiver PhysiologyWater-soluble Prodrugs	2000	95
Characterization of a Novel, Non-peptidyl Antagonist of the Human Glucagon Receptor Margaret A. Cascieri, Gregory Koch, Elżbieta Ber, Journal of Biological Chemistry	1999	92
N-Acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists Angus M. MacLeod, Kevin J. Merchant, Margaret A. Cascieri, Journal of Medicinal Chemistry Pharmaceutical ScienceAltmetric Attention ScorePharmacotherapyPre-clinical PharmacologyMolecular Pharmacology	1993	71
Zinc deficiency and the Euglena gracilis chromatin: formation of an .alpha.-amanitin-resistant RNA polymerase II Kenneth H. Falchuk, B Mazuś, Elżbieta Ber, Biochemistry	1985	23
Characterization of the binding and activity of a high affinity, pseudoirreversible morpholino tachykinin NK1 receptor antagonist Margaret A. Cascieri, Elżbieta Ber, Tung M. Fong, European Journal of Pharmacology Signal TransductionFunctional SelectivityMedicineG Protein-coupled ReceptorImmunology	1997	12

Page 1